IMR Press / EJGO / Volume 25 / Issue 3 / Pii/2004165

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.


Successful vaccine irnrnunotherapy. An exciting novel approach to cancer treatment

Show Less
1 First Department of Obstetrics and Gynaecology, Alexandra Hospital, University of Athens, Athens (Greece)
Eur. J. Gynaecol. Oncol. 2004, 25(3), 287–291;
Published: 10 June 2004

Global cancer spread to pandemic proportions, has reinforced the importance of disease surveillance and prevention pro­grams, and has provided the stimulus for greater resources in vaccine development. Many reports from phase I or II trials indicate that both partial and complete responses have been observed, with little or no toxicity, in a small proportion of vaccine recipients. Future prospects will be to increase basic knowledge of immunogenic tumor antigens to vaccine admin­istration, which will make the cancer patient develop an immune response able to induce tumor regression. Clinical trials already under way in patients with malignant diseases may yield more definitive conclusions.

Back to top